Logo image of CE.MI

CREDITO EMILIANO SPA (CE.MI) Stock Fundamental Analysis

BIT:CE - Euronext Milan - IT0003121677 - Common Stock - Currency: EUR

12.32  +0.02 (+0.16%)

Fundamental Rating

3

CE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 93 industry peers in the Banks industry. While CE is still in line with the averages on profitability rating, there are concerns on its financial health. CE is valued correctly, but it does not seem to be growing. Finally CE also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CE had positive earnings in the past year.
In the past year CE has reported a negative cash flow from operations.
Each year in the past 5 years CE has been profitable.
CE had a positive operating cash flow in 4 of the past 5 years.
CE.MI Yearly Net Income VS EBIT VS OCF VS FCFCE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

CE's Return On Assets of 1.39% is amongst the best of the industry. CE outperforms 88.17% of its industry peers.
The Return On Equity of CE (21.97%) is better than 96.77% of its industry peers.
Industry RankSector Rank
ROA 1.39%
ROE 21.97%
ROIC N/A
ROA(3y)0.74%
ROA(5y)0.62%
ROE(3y)12.8%
ROE(5y)11%
ROIC(3y)N/A
ROIC(5y)N/A
CE.MI Yearly ROA, ROE, ROICCE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

CE has a Profit Margin (22.80%) which is in line with its industry peers.
CE's Profit Margin has improved in the last couple of years.
CE does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 22.8%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y9.66%
PM growth 5Y15.69%
GM growth 3YN/A
GM growth 5YN/A
CE.MI Yearly Profit, Operating, Gross MarginsCE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1

2. Health

2.1 Basic Checks

CE does not have a ROIC to compare to the WACC, probably because it is not profitable.
CE has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CE has been increased compared to 5 years ago.
CE has a better debt/assets ratio than last year.
CE.MI Yearly Shares OutstandingCE.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CE.MI Yearly Total Debt VS Total AssetsCE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

A Debt/Equity ratio of 2.85 is on the high side and indicates that CE has dependencies on debt financing.
CE has a worse Debt to Equity ratio (2.85) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.85
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC4.92%
CE.MI Yearly LT Debt VS Equity VS FCFCE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CE.MI Yearly Current Assets VS Current LiabilitesCE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.98% over the past year.
CE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.45% yearly.
Looking at the last year, CE shows a decrease in Revenue. The Revenue has decreased by -8.95% in the last year.
CE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.25% yearly.
EPS 1Y (TTM)16.98%
EPS 3Y20.15%
EPS 5Y24.45%
EPS Q2Q%42.22%
Revenue 1Y (TTM)-8.95%
Revenue growth 3Y10.09%
Revenue growth 5Y8.25%
Sales Q2Q%-19.92%

3.2 Future

Based on estimates for the next years, CE will show a decrease in Earnings Per Share. The EPS will decrease by -4.37% on average per year.
The Revenue is expected to decrease by -0.74% on average over the next years.
EPS Next Y-17.36%
EPS Next 2Y-10.85%
EPS Next 3Y-6.94%
EPS Next 5Y-4.37%
Revenue Next Year-6.09%
Revenue Next 2Y-2.84%
Revenue Next 3Y-1.18%
Revenue Next 5Y-0.74%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CE.MI Yearly Revenue VS EstimatesCE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
CE.MI Yearly EPS VS EstimatesCE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

CE is valuated cheaply with a Price/Earnings ratio of 4.15.
Compared to the rest of the industry, the Price/Earnings ratio of CE indicates a rather cheap valuation: CE is cheaper than 97.85% of the companies listed in the same industry.
CE is valuated cheaply when we compare the Price/Earnings ratio to 26.92, which is the current average of the S&P500 Index.
CE is valuated reasonably with a Price/Forward Earnings ratio of 8.38.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CE indicates a somewhat cheap valuation: CE is cheaper than 72.04% of the companies listed in the same industry.
CE is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.49, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.15
Fwd PE 8.38
CE.MI Price Earnings VS Forward Price EarningsCE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CE.MI Per share dataCE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

CE's earnings are expected to decrease with -6.94% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.17
EPS Next 2Y-10.85%
EPS Next 3Y-6.94%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.10%, CE is a good candidate for dividend investing.
CE's Dividend Yield is a higher than the industry average which is at 5.14.
Compared to an average S&P500 Dividend Yield of 2.43, CE pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.1%

5.2 History

On average, the dividend of CE grows each year by 26.52%, which is quite nice.
Dividend Growth(5Y)26.52%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

CE pays out 23.47% of its income as dividend. This is a sustainable payout ratio.
DP23.47%
EPS Next 2Y-10.85%
EPS Next 3Y-6.94%
CE.MI Yearly Income VS Free CF VS DividendCE.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B
CE.MI Dividend Payout.CE.MI Dividend Payout, showing the Payout Ratio.CE.MI Dividend Payout.PayoutRetained Earnings

CREDITO EMILIANO SPA

BIT:CE (6/27/2025, 7:00:00 PM)

12.32

+0.02 (+0.16%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)05-08 2025-05-08
Earnings (Next)08-05 2025-08-05
Inst Owners7.05%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.21B
Analysts80
Price Target13.28 (7.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.1%
Yearly Dividend0.65
Dividend Growth(5Y)26.52%
DP23.47%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.27%
PT rev (3m)2.63%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.41%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.48%
Valuation
Industry RankSector Rank
PE 4.15
Fwd PE 8.38
P/S 1.02
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 1.11
EV/EBITDA N/A
EPS(TTM)2.97
EY24.11%
EPS(NY)1.47
Fwd EY11.93%
FCF(TTM)-5.59
FCFYN/A
OCF(TTM)-5.25
OCFYN/A
SpS12.12
BVpS12.58
TBVpS11.11
PEG (NY)N/A
PEG (5Y)0.17
Profitability
Industry RankSector Rank
ROA 1.39%
ROE 21.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 22.8%
GM N/A
FCFM N/A
ROA(3y)0.74%
ROA(5y)0.62%
ROE(3y)12.8%
ROE(5y)11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y9.66%
PM growth 5Y15.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 2.85
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 105.32%
Cap/Sales 2.74%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC4.92%
ROIC/WACCN/A
Cap/Depr(3y)105.98%
Cap/Depr(5y)113.67%
Cap/Sales(3y)4.46%
Cap/Sales(5y)4.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.98%
EPS 3Y20.15%
EPS 5Y24.45%
EPS Q2Q%42.22%
EPS Next Y-17.36%
EPS Next 2Y-10.85%
EPS Next 3Y-6.94%
EPS Next 5Y-4.37%
Revenue 1Y (TTM)-8.95%
Revenue growth 3Y10.09%
Revenue growth 5Y8.25%
Sales Q2Q%-19.92%
Revenue Next Year-6.09%
Revenue Next 2Y-2.84%
Revenue Next 3Y-1.18%
Revenue Next 5Y-0.74%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-162%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-156.25%
OCF growth 3YN/A
OCF growth 5YN/A